These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 29643258)

  • 1. Prevalence of Poststroke Neurocognitive Disorders Using National Institute of Neurological Disorders and Stroke-Canadian Stroke Network, VASCOG Criteria (Vascular Behavioral and Cognitive Disorders), and Optimized Criteria of Cognitive Deficit.
    Barbay M; Taillia H; Nédélec-Ciceri C; Bompaire F; Bonnin C; Varvat J; Grangette F; Diouf M; Wiener E; Mas JL; Roussel M; Godefroy O;
    Stroke; 2018 May; 49(5):1141-1147. PubMed ID: 29643258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychological assessment and cerebral vascular disease: the new standards.
    Godefroy O; ; Leclercq C; Bugnicourt JM; Roussel M; Moroni C; Quaglino V; Beaunieux H; Taillia H; Nédélec-Ciceri C; Bonnin C; Thomas-Anterion C; Varvat J; Aboulafia-Brakha T; Assal F
    Rev Neurol (Paris); 2013 Oct; 169(10):779-85. PubMed ID: 23999023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular cognitive disorders and depression after first-ever stroke: the Fogarty-Mexico Stroke Cohort.
    Arauz A; Rodríguez-Agudelo Y; Sosa AL; Chávez M; Paz F; González M; Coral J; Díaz-Olavarrieta C; Román GC
    Cerebrovasc Dis; 2014; 38(4):284-9. PubMed ID: 25412708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic Review and Meta-Analysis of Prevalence in Post-Stroke Neurocognitive Disorders in Hospital-Based Studies.
    Barbay M; Diouf M; Roussel M; Godefroy O;
    Dement Geriatr Cogn Disord; 2018; 46(5-6):322-334. PubMed ID: 30504699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 2 Diabetes Mellitus and Impaired Renal Function Are Associated With Brain Alterations and Poststroke Cognitive Decline.
    Ben Assayag E; Eldor R; Korczyn AD; Kliper E; Shenhar-Tsarfaty S; Tene O; Molad J; Shapira I; Berliner S; Volfson V; Shopin L; Strauss Y; Hallevi H; Bornstein NM; Auriel E
    Stroke; 2017 Sep; 48(9):2368-2374. PubMed ID: 28801477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence Rates of Dementia and Mild Cognitive Impairment Are Affected by the Diagnostic Parameter Changes for Neurocognitive Disorders in the DSM-5 in a Korean Population.
    Han JW; So Y; Kim TH; Lee DY; Ryu SH; Kim SY; Kim SG; Kim SK; Youn JC; Jhoo JH; Kim JL; Lee SB; Lee JJ; Kwak KP; Moon SW; Kim BJ; Bae JN; Woo JI; Jeong H; Park JH; Kim YJ; Kim KW
    Dement Geriatr Cogn Disord; 2017; 43(3-4):193-203. PubMed ID: 28237992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Who should undergo a comprehensive cognitive assessment after a stroke? A cognitive risk score.
    Godefroy O; Yaïche H; Taillia H; Bompaire F; Nédélec-Ciceri C; Bonnin C; Varvat J; Vincent-Grangette F; Diouf M; Mas JL; Canaple S; Lamy C; Arnoux A; Leclercq C; Tasseel-Ponche S; Roussel M; Barbay M;
    Neurology; 2018 Nov; 91(21):e1979-e1987. PubMed ID: 30333160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Vascular Behavioral and Cognitive Disorders criteria for vascular cognitive disorders: a validation study.
    Sachdev PS; Lipnicki DM; Crawford JD; Brodaty H
    Eur J Neurol; 2019 Sep; 26(9):1161-1167. PubMed ID: 30927497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic utility of Montreal Cognitive Assessment in the Fifth Edition of Diagnostic and Statistical Manual of Mental Disorders: major and mild neurocognitive disorders.
    Liew TM; Feng L; Gao Q; Ng TP; Yap P
    J Am Med Dir Assoc; 2015 Feb; 16(2):144-8. PubMed ID: 25282632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroimaging Determinants of Poststroke Cognitive Performance.
    Puy L; Barbay M; Roussel M; Canaple S; Lamy C; Arnoux A; Leclercq C; Mas JL; Tasseel-Ponche S; Constans JM; Godefroy O;
    Stroke; 2018 Nov; 49(11):2666-2673. PubMed ID: 30355190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of cerebral microbleeds predicts reversion of vascular 'cognitive impairment no dementia' in stroke.
    Tang WK; Chen YK; Lu JY; Wong A; Mok V; Chu WC; Ungvari GS; Wong KS
    Int J Stroke; 2011 Dec; 6(6):498-505. PubMed ID: 22111793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Behavioral and Cognitive Executive Disorders of Stroke: The GREFEX Study.
    Roussel M; Martinaud O; Hénon H; Vercelletto M; Bindschadler C; Joseph PA; Robert P; Labauge P; Godefroy O;
    PLoS One; 2016; 11(1):e0147602. PubMed ID: 26824746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How common are neurocognitive disorders in patients with chronic kidney disease and diabetes? Results from a cross-sectional study in a community cohort of patients in North Wales, UK.
    Hobson P; Lewis A; Nair H; Wong S; Kumwenda M
    BMJ Open; 2018 Dec; 8(12):e023520. PubMed ID: 30518585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical Frailty, Cognitive Impairment, and the Risk of Neurocognitive Disorder in the Singapore Longitudinal Ageing Studies.
    Feng L; Nyunt MS; Gao Q; Feng L; Lee TS; Tsoi T; Chong MS; Lim WS; Collinson S; Yap P; Yap KB; Ng TP
    J Gerontol A Biol Sci Med Sci; 2017 Mar; 72(3):369-375. PubMed ID: 27013397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Test Accuracy of the Montreal Cognitive Assessment in Screening for Early Poststroke Neurocognitive Disorder: The Nor-COAST Study.
    Munthe-Kaas R; Aam S; Saltvedt I; Wyller TB; Pendlebury ST; Lydersen S; Ihle-Hansen H
    Stroke; 2021 Jan; 52(1):317-320. PubMed ID: 33250039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a research diagnostic algorithm for DSM-5 neurocognitive disorders in a population-based cohort of older adults.
    Eramudugolla R; Mortby ME; Sachdev P; Meslin C; Kumar R; Anstey KJ
    Alzheimers Res Ther; 2017 Mar; 9(1):15. PubMed ID: 28259179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neurocognitive disorder cohort RIFADE: Aims, methods, first results showing cognitive improvement in a subgroup.
    Baumann B; Lipka T; Jänner M; Kujovic M
    Eur Arch Psychiatry Clin Neurosci; 2023 Jun; 273(4):941-952. PubMed ID: 36416960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A two year longitudinal study of poststroke mood disorders: prognostic factors related to one and two year outcome.
    Parikh RM; Lipsey JR; Robinson RG; Price TR
    Int J Psychiatry Med; 1988; 18(1):45-56. PubMed ID: 3397225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the prevalence of substance-induced neurocognitive disorder among polysubstance users, adding subjective and objective evidence of cognitive impairment.
    Toledo-Fernández A; Marín-Navarrete R; Villalobos-Gallegos L; Salvador-Cruz J; Benjet C; Roncero C
    Psychiatry Res; 2020 Jun; 288():112944. PubMed ID: 32339804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mild Neurocognitive Disorder: An Old Wine in a New Bottle.
    Stokin GB; Krell-Roesch J; Petersen RC; Geda YE
    Harv Rev Psychiatry; 2015; 23(5):368-76. PubMed ID: 26332219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.